GKOS 8-K 2026-11-06

GLAUKOS Corp (GKOS) 8-K dated 2026-11-06 — accession 0001193125-26-450710.

GLAUKOS Corp (GKOS) is a medical devices company listed on NYSE.

GLAUKOS Corp filed a 8-K on 2026-11-06. Accession 0001193125-26-450710.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GKOS revenue for 2025-12-31 was $507.4M. Net income was -$187.7M. Revenue was up 32.3% from 2024-12-31 to 2025-12-31. GKOS currently screens at market cap $7.63B.

Not investment advice. The GKOS SEC hub lists recent forms. The stock page is the research view.